BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 11326697)

  • 21. Quality improvement of diagnostic microbiology through a peer-group proficiency assessment program. A 20-year experience in Ontario. The Microbiology Committee.
    Richardson H; Wood D; Whitby J; Lannigan R; Fleming C
    Arch Pathol Lab Med; 1996 May; 120(5):445-55. PubMed ID: 8639047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Domestic and international trends concerning allowable limits of error in external quality assessment scheme].
    Hosogaya S; Ozaki Y
    Rinsho Byori; 2005 Jun; 53(6):547-53. PubMed ID: 16026083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of three quality control investigations on radioimmunological determination of thyrotropin using the "Munich model"].
    Marschner I; Wood WG; van Thiel D; Habermann J; König A; Scriba PC
    J Clin Chem Clin Biochem; 1983 May; 21(5):301-11. PubMed ID: 6875478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.
    Westgard JO; Bawa N; Ross JW; Lawson NS
    Arch Pathol Lab Med; 1996 Jul; 120(7):621-5. PubMed ID: 8757464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External quality control survey for alpha-fetoprotein assay.
    Zucchelli GC; Pilo A; Ferdeghini M; Chiesa MR; Masini A; Clerico A
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):30-3. PubMed ID: 2480418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality control and quality assurance.
    Laessig RH; Ehrmeyer SS; Hassemer DJ
    Clin Lab Med; 1986 Jun; 6(2):317-27. PubMed ID: 3720254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precision and accuracy: concepts and assessment by method evaluation testing.
    Westgard JO
    Crit Rev Clin Lab Sci; 1981; 13(4):283-330. PubMed ID: 7016436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of human serum based tumor marker control.
    Chapman D; Fontana L
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):114-7. PubMed ID: 2593008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multi-center quality control study of different CA15-3 immunoassays.
    Hubl W; Demant T; Albrecht S; Bewarder N; Grunow G; Keller R; Klapdor R; Klos KJ; Kruse K; Müller R; Päge I; Schmidt R; Stolle H; Wiefelspütz J; vom Baur E; Zinsmeyer J; Zwirner M
    Clin Lab; 2005; 51(11-12):641-5. PubMed ID: 16329622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keeping waived tests simple.
    Clin Leadersh Manag Rev; 2004; 18(1):65-9. PubMed ID: 14968759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the stability of Cell Dyn 16 Tri Level as a control material for laboratory external quality assessment scheme on hematology.
    Aulia D; Wirawan R; Timan IS; Indrasari N
    Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():115-23. PubMed ID: 12755281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internal quality control of the malaria microscopy diagnosis for 10 laboratories on the Thai-Myanmar border.
    Hemme F; Gay F
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):529-36. PubMed ID: 10437951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quality control in tumor marker values: methology, results and potential problems].
    Ben Ayed M; Ben Hadj Hmida Y; Kassis M; Damak J; Masmoudi H
    Tunis Med; 2001; 79(6-7):341-7. PubMed ID: 11771428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays.
    Wong R; Favaloro E; Pollock W; Wilson R; Hendle M; Adelstein S; Baumgart K; Homes P; Smith S; Steele R; Sturgess A; Gillis D
    Pathology; 2004 Apr; 36(2):182-92. PubMed ID: 15203756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Present status and problems of external quality assurance program of Japan Medical Association].
    Takagi Y
    Rinsho Byori; 2005 Jun; 53(6):540-6. PubMed ID: 16026082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the implementation of HIV-rapid test kits at different levels of health institutions in Ethiopia.
    Tegbaru B; Wolday D; Messele T; Meless H; Kassa D; Tesema D; Tamene W; Ahmedin Z; Adane A; Tebeje M; Gezahegn N; Birhanu H; Mengistu Y; Wuhib T; Fekadu M
    Ethiop Med J; 2007 Jul; 45(3):293-9. PubMed ID: 18330330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PACP regional quality control program: a general survey.
    Dharan M
    Am J Med Technol; 1975 Jul; 41(7):249-55. PubMed ID: 1163554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.